Rapid Acting Antidepressants: Advances in Pharmacology, cartea 89
Ronald S. Duman, John H. Krystalen Limba Engleză Hardback – 25 iun 2020
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Din seria Advances in Pharmacology
- 5%
Preț: 531.23 lei - 5%
Preț: 540.70 lei - 5%
Preț: 532.44 lei - 23%
Preț: 429.96 lei - 5%
Preț: 549.32 lei - 5%
Preț: 1884.00 lei - 5%
Preț: 1883.14 lei - 5%
Preț: 1891.35 lei - 29%
Preț: 1001.55 lei - 29%
Preț: 1127.77 lei - 27%
Preț: 1456.12 lei - 27%
Preț: 1450.21 lei - 5%
Preț: 1790.59 lei - 5%
Preț: 1799.87 lei - 5%
Preț: 1788.05 lei - 5%
Preț: 1789.84 lei - 5%
Preț: 1793.78 lei - 5%
Preț: 1803.82 lei - 29%
Preț: 1070.14 lei - 29%
Preț: 1075.71 lei - 32%
Preț: 1023.37 lei - 29%
Preț: 1074.64 lei - 29%
Preț: 1072.40 lei - 32%
Preț: 1027.67 lei - 9%
Preț: 1029.40 lei - 29%
Preț: 1069.62 lei - 29%
Preț: 1075.01 lei - 29%
Preț: 1070.70 lei - 29%
Preț: 1069.89 lei - 25%
Preț: 1067.44 lei - 29%
Preț: 1067.71 lei - 29%
Preț: 1068.43 lei - 24%
Preț: 1146.84 lei - 24%
Preț: 1145.97 lei - 25%
Preț: 1068.72 lei - 16%
Preț: 1205.90 lei - 15%
Preț: 1211.84 lei - 25%
Preț: 1072.04 lei - 25%
Preț: 1071.05 lei - 25%
Preț: 1071.48 lei - 25%
Preț: 1070.06 lei - 25%
Preț: 1073.61 lei
Preț: 1147.95 lei
Preț vechi: 1679.92 lei
-32% Nou
Puncte Express: 1722
Preț estimativ în valută:
219.73€ • 230.40$ • 181.55£
219.73€ • 230.40$ • 181.55£
Carte tipărită la comandă
Livrare economică 22 ianuarie-05 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128201893
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
Public țintă
investigators in neuroscience, pharmacology, neurology, psychiatry, medicine.Cuprins
Part I – Neurobiology of ketamine effects
- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmissionAllie J. Widman and Lori L. McMahon
- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibitionBernhard Luscher, Mengyang Feng and Sarah J. Jefferson
- The role of eEF2 kinase in the rapid antidepressant actions of ketamineKanzo Suzuki and Lisa M. Monteggia
Part II – The rapid therapeutic effects of ketamine - Clinical overview of NMDA-R antagonists and clinical practicePasha A. Davoudian and Samuel T. Wilkinson
- Ketamine for depression clinical issuesSyed Z. Iqbal and Sanjay J. Mathew
- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidenceLynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
- Neurobiological biomarkers of response to ketamineBashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressantsJaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
- The emergence of ketamine as a novel treatment for posttraumatic stress disorderAdriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney
Part III – Novel rapid-acting antidepressant mechanisms related to ketamine - mGlu2/3 receptor as a novel target for rapid acting antidepressantsShigeyuki Chaki
- Involvement of muscarinic receptor mechanisms in antidepressant drug actionJeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions